CLINICAL_TRIALS
trial_result
· 2025-05-31
Clinical Trial Update: Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Homozygous Familial Hypercholesterolemia [Phase 3]
Summary
A Phase 3 trial evaluating the efficacy and safety of inclisiran in adolescents with homozygous familial hypercholesterolemia has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Familial Hypercholesterolemia - Homozygous | Phase 3 | Status: COMPLETED | Results posted: 2025-05-31